Minimally Invasive Heart Valve Therapies Drive Growth Amid Rising Cardiovascular Burden and Aging Population
Noida, India – July 11, 2025 – According to a new report by Renub Research, the Global Transcatheter Heart Valve Replacement (THVR) Market is expected to grow from US$ 7.10 billion in 2024 to US$ 19.69 billion by 2033, expanding at a strong CAGR of 12.00% between 2025 and 2033. This surge is driven by a growing aging population, increasing prevalence of cardiovascular diseases (CVDs), and rapid advancements in minimally invasive surgical technologies.
Transcatheter heart valve replacement—also known as transcatheter valve therapy—is revolutionizing cardiac treatment by offering less-invasive alternatives to traditional open-heart surgeries. With better procedural success rates, reduced hospital stays, and faster patient recovery times, THVR is increasingly becoming the standard of care for high-risk and elderly patients.
For a full breakdown and in-depth analysis, visit:
👉 Transcatheter Heart Valve Replacement Market – Renub Research
Aging Population and Rise in Cardiovascular Diseases Fuel Market Demand
The burden of cardiovascular disorders such as aortic stenosis, mitral regurgitation, and valve insufficiencies is increasing globally, especially among people aged 65 and above. As per the WHO, CVDs remain the leading cause of death worldwide, with heart valve diseases representing a significant and rising component.
With an aging global population and associated comorbidities, the demand for safe, effective, and less traumatic surgical alternatives has increased dramatically. Transcatheter procedures address these needs, providing life-saving interventions for patients who are not candidates for conventional open-heart surgeries.
Technological Innovations Elevate Procedure Success and Safety
The growth of the THVR market is also propelled by significant technological advancements in valve design, delivery systems, and imaging guidance. These innovations have improved:
-
Precision in valve positioning
-
Reduced procedural complications
-
Lower paravalvular leak risks
-
Improved durability of biological valves
Next-generation transcatheter aortic, mitral, and pulmonary valves offer enhanced hemodynamic performance and compatibility with challenging anatomies. Further, the rise of robotic-assisted catheterization, 3D imaging, and real-time navigation systems is transforming procedure efficacy and physician confidence.
Market Segmentation: Valve Type, Material, and End-Users
Renub Research’s comprehensive report segments the market as follows:
By Type:
-
Transcatheter Aortic Valve Replacement (TAVR) – Dominant segment due to widespread use for treating aortic stenosis.
-
Transcatheter Mitral Valve Replacement (TMVR) – Rapidly growing due to unmet clinical needs in mitral valve disorders.
-
Transcatheter Pulmonary Valve Replacement (TPVR) – Gaining attention for use in congenital heart defect patients and pediatric cases.
TAVR continues to lead in adoption globally; however, TMVR is expected to register the fastest growth, as more devices are approved and clinical trials confirm safety and efficacy.
By Material:
-
Biological Valves (Tissue Valves) – Leading segment due to superior biocompatibility and lower thromboembolic risk.
-
Mechanical Valves – Still used in younger patients but associated with lifelong anticoagulation needs.
The shift toward biological valves aligns with the rising elderly population, who prefer lower-maintenance devices with minimal follow-up treatment.
By End-User:
-
Hospitals – Major share due to availability of catheter labs and cardiovascular surgery infrastructure.
-
Ambulatory Surgical Centers (ASCs) – Gaining traction due to shorter wait times and cost-effective procedures.
-
Others – Includes specialty cardiac clinics and research institutes.
Hospitals remain the primary venue for THVR procedures, but ASCs are forecasted to witness significant growth as same-day discharge protocols and minimally invasive techniques become more mainstream.
Regional Insights: North America Leads, Asia-Pacific Offers Untapped Potential
North America
North America dominates the THVR market due to:
-
High incidence of valvular heart diseases
-
Strong presence of major device manufacturers
-
Favorable reimbursement environment (e.g., Medicare coverage for TAVR)
-
Extensive clinical research and early adoption of next-gen valves
Europe
Europe follows closely behind, with countries like Germany, France, and the UK adopting THVR at a fast pace. The European Society of Cardiology (ESC) guidelines support early interventions using minimally invasive options for eligible patients.
Asia-Pacific
The Asia-Pacific region is expected to be the fastest-growing market during the forecast period, thanks to:
-
Growing aging populations in China, Japan, and India
-
Expansion of private healthcare
-
Increasing awareness of advanced valve replacement therapies
However, market penetration remains limited due to cost barriers and limited reimbursement policies in some countries, offering a major growth opportunity for both public and private stakeholders.
Competitive Landscape: Innovation and M&A Shape the Industry
The THVR market is highly competitive, with leading companies focusing on R&D, strategic acquisitions, and regulatory approvals to maintain or expand their market share. Key players profiled in Renub Research’s report include:
-
Edwards Lifesciences Corporation
-
Medtronic plc
-
Abbott Laboratories
-
Boston Scientific Corporation
-
JenaValve Technology
-
LivaNova PLC
-
Meril Life Sciences
-
CryoLife Inc.
Edwards and Medtronic dominate the TAVR space, while newer players are entering the TMVR and TPVR segments through clinical innovations and collaborative partnerships with hospitals and research institutions.
Patient Preference Shifts Toward Minimally Invasive Options
Patients are increasingly opting for transcatheter heart valve replacements over traditional open-heart surgeries due to:
-
Shorter recovery periods
-
Less postoperative pain
-
Reduced need for ICU stays
-
Lower complication rates
This shift is especially relevant in the post-COVID-19 era, where hospitals and patients prioritize minimally invasive and outpatient care models.
Market Challenges: Cost and Access Limit Widespread Adoption
Despite rapid growth, several challenges remain:
-
High costs of devices and procedures, limiting accessibility in low- and middle-income countries
-
Complex training requirements for surgeons and cardiologists
-
Reimbursement disparities across regions
-
Durability concerns for long-term outcomes in younger patients
To overcome these challenges, manufacturers and healthcare providers are exploring:
-
Value-based pricing
-
Government-supported subsidy programs
-
Training partnerships with academic institutions
-
Cost-effective valve materials and delivery systems
Future Outlook: A Transformative Decade for Cardiac Care
As cardiovascular healthcare shifts toward less invasive, more efficient, and personalized treatment models, the global THVR market is expected to continue expanding. Innovations in artificial intelligence (AI), robotics, and bioengineering are likely to redefine how valve replacement surgeries are planned, executed, and monitored.
In the coming decade, transcatheter heart valve therapies will play a pivotal role in reducing the global heart disease burden and offering new hope to millions of patients worldwide.
New Publish Report:
- Global Jam, Jelly & Preserves Market – Consumer Insights & Forecast 2025–2033
- Global Fashion Accessories Market – Style Trends & Forecast 2025–2033
- Global Factoring Services Market – Financial Solutions & Forecast 2025–2033
About the Company
Renub Research is a Market Research and Consulting Company with more than 15 years of experience, especially in international Business-to-Business Research, Surveys, and Consulting. We provide a wide range of business research solutions that help companies make better business decisions. We partner with clients across all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
Our wide clientele includes key players in Healthcare, Travel & Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemicals, Logistics & Automotive, Consumer Goods & Retail, Building & Construction, and Agriculture. Our core team comprises experienced professionals with graduate, postgraduate, and Ph.D. qualifications in Finance, Marketing, Human Resources, Bio-Technology, Medicine, Information Technology, Environmental Science, and more.
Media Contact
Company Name: Renub Research
Contact Person: Rajat Gupta, Marketing Manager
Phone No: +91-120-421-9822 (IND) | +1-478-202-3244 (USA)
Email: rajat@renub.com
Website: https://www.renub.com/united-states-wedding-services-market-p.php